WHO ICTRP trial
A phase II clinical study of Chang-Ji-An Capsule
ChiCTR1800017664 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800017664 |
|---|---|
| Public title | A phase II clinical study of Chang-Ji-An Capsule |
| Scientific title | A randomized, double-blind single-simulation, placebo as a parallel control, multicenter clinical study for preliminarily evaluation of the efficacy and safety of Chang-Ji-An Capsule in the treatment of patients with diarrhea-predominant irritable bowel syndrome |
| Primary sponsor | Beijing Chinese Medicine Hospital affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Diarrhea-type irritable bowel syndrome |
| Interventions | Group 1:taking Chang-Ji-An capsule;control group:taking Chang-Ji-An capsule placebo |
| Registration date | Aug 8, 2018 |
| Target size | Group 1:120;control group:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: